Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

Question 2

How does LX9211 compare to my current pain management options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with LX9211?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will the trial last, and what will my treatment involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain clinical trial (NCT04455633). Contact the study team or your healthcare provider for specific answers.

What this study is about